HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Claus Bartels Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bechtel, J.F. M. Articles by Bartels, C. Search for Related Content PubMed PubMed Citation Articles by Bechtel, J.F. M. Articles by Bartels, C.

Ann Thorac Surg 2002;74:390-393
© 2002 The Society of Thoracic Surgeons

---

Original article: cardiovascular

Is the kaolin or celite activated clotting time affected by tranexamic acid?

^a Department of Cardiac Surgery, University Hospital of Luebeck, Luebeck, Germany

Accepted for publication April 30, 2002.

* Address reprint requests to Dr Bartels, Klinik für Herzchirurgie, Universitaetsklinikum Luebeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany
e-mail: bartels{at}medinf.mu-luebeck.de

Background. During cardiopulmonary bypass, the activated clotting time is frequently used for determination of anticoagulation, and either Celite or kaolin are used as activators. If aprotinin is administered concomitantly, the Celite activated clotting time (C-ACT) becomes significantly higher than the kaolin activated clotting time (K-ACT). Therefore, insufficient anticoagulation using C-ACT in the presence of aprotinin is a major concern. Whether the application of tranexamic acid (TA), a pharmacologic alternative to aprotinin, has similar effects has not been studied before.

Methods. An in vitro study using the blood of healthy volunteers was performed. Both C-ACT and K-ACT were measured at baseline, after adding TA, and after adding TA and heparin. In addition, 30 patients undergoing primary cardiac operations had simultaneous measurements of C-ACT and K-ACT after skin-incision, 5 minutes after the application of heparin and TA, every 30 minutes during cardiopulmonary bypass, and 10 minutes after the application of protamine.

Results. In vitro, C-ACT and K-ACT correlated significantly at each measurement. Tranexamic acid had no influence on the activated clotting time. In vivo, C-ACT and K-ACT did not differ significantly, but at each time C-ACT tended to be greater than K-ACT (p = 0.086). The average difference between K-ACT and C-ACT was stable before and after the application of TA (p = 0.85) but the variability of the differences significantly increased during cardiopulmonary bypass (p < 0.001).

Conclusions. Application of TA does not seem to differentially affect the mean C-ACT and K-ACT. No recommendation seems warranted to prefer one activator over the other in patients receiving TA.

This article has been cited by other articles:

				M. T. Ganter, S. Dalbert, K. Graves, R. Klaghofer, A. Zollinger, and C. K. Hofer Monitoring Activated Clotting Time for Combined Heparin and Aprotinin Application: An In Vitro Evaluation of a New Aprotinin-Insensitive Test Using SONOCLOT Anesth. Analg., August 1, 2005; 101(2): 308 - 314. [Abstract] [Full Text] [PDF]